Company / Total Assets
PUMA BIOTECHNOLOGY, INC. Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$216.3M
FY2025
5-year range
$213.3M / $230.5M
FY2021-FY2025
Trend
+1.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 9 years, ranging from $166M in FY2017 to $259M in FY2018.
Based on SEC 10-K filings.
$216M in FY2025 with a 5-year CAGR of -2.4%.
Declined from $231M to $216M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -0.9%
- 5-Year CAGR
- -2.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -2.4%, indicating a declining trend.
- In FY2025, total assets increased 1.4% year-over-year.
- Peak total assets was recorded in FY2018.
- Lowest total assets in the period was in FY2017.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $216.3M | +1.4% |
| FY2024 | $213.3M | -7.5% |
| FY2023 | $230.5M | +3.8% |
| FY2022 | $222.1M | -2.0% |
| FY2021 | $226.6M | -7.2% |
| FY2020 | $244.2M | +4.0% |
| FY2019 | $234.9M | -9.3% |
| FY2018 | $259.1M | +56.5% |
| FY2017 | $165.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026